John F. Milligan, President & CEO, Director at Gilead Sciences, holds 100.00K shares in 4D Molecular Therapeutics (Ticker: FDMT), holds 110.00K shares in Pacific Biosciences (Ticker: PACB), holds 1.57M shares in Gilead Sciences (Ticker: GILD). Most recently, John F. Milligan Bought ― shares of 4D Molecular Therapeutics on Dec 17, 2020 for an estimated value of 2.30M.